NMR Verification of Structures of Bacterial Saccharide Precursors for Vaccines

疫苗用细菌糖前体结构的核磁共振验证

基本信息

项目摘要

During the year, a further 17 monosaccharide and oligosaccharide intermediates of Vibrio cholera antigens, for the preparation of a hexasaccharide-protein conjugate have been analyzed by high-resolution one-dimensional (1D) H-1 and 1D C-13 NMR at 500 MHz and 126 MHz, respectively, making a cumulative total of 80. Validation of the chemical structures was based on integration of the 1D H-1 NMR spectra, and on counting of carbon resonances in the 13C spectra, especially in the well-separated spectral regions of the C=O, aromatic C, C-1, C-N, and C-CH3 moieties. The NMR spectra were also used to assess the purity of the synthetic preparations, for example, determination of the extent of completion of hydrogenolytic removal of benzyl protecting groups by measurement of the content of aromatic groups. H-1 NMR spectra at 500 MHz have been measured for the characterization of 12 native polysaccharide fractions isolated from Shigella sonnei. Comparison of the integrals of the polysaccharide H-1 and rhamnose methyl signals facilitated detection and quantitation of core polysaccharide in the samples. The techniques provide complex fingerprint spectra that can be compared with literature data to verify identity. A sample of the E. coli O148 O-specific polysaccharide has been characterized by H-1 NMR. When we came to publish our work on immunochemical studies of Shigella flexneri 2a and 6, etc, a referee of the manuscript was concerned that acetyl groups on the polysaccharide might react with our conjugation-assisting reagent O-(3-thiopropyl)hydroxylamine, under the conditions of the conjugation reaction. We therefore conducted a study in which the O-SP of S. flexneri 6 was treated with an equimolar proportion of the hydroxylamine derivative under these conditions. The solution in D2O was monitored by H-1 NMR spectroscopy at various times over a period of 22 h. No changes in the relative intensities of the OAc and NAc resonances of the polysaccharide or in any other parts of the spectra were observed that would indicate an on-going chemical reaction.
本年度,分别在500 MHz和126 MHz高分辨率一维H-1和一维C-13核磁共振分析了霍乱弧菌抗原的17个单糖和寡糖中间体,用于制备六糖-蛋白偶联物,累计总数为80个。化学结构的验证是基于一维H-1核磁共振谱的整合,以及13C光谱中的碳共振计数,特别是在C=O,芳香C, C-1, C- n和C- ch3部分的分离良好的光谱区域。核磁共振光谱还用于评价合成产物的纯度,例如,通过测定芳香族的含量来确定苯保护基团的氢解去除完成程度。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rachel Schneerson其他文献

Rachel Schneerson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rachel Schneerson', 18)}}的其他基金

NMR Verification of Structures of Bacterial Saccharide Precursors for Vaccines
疫苗用细菌糖前体结构的核磁共振验证
  • 批准号:
    7968700
  • 财政年份:
  • 资助金额:
    $ 0.7万
  • 项目类别:
Cross Reacting Polysaccharides (H. influenzae types a and b, and B. pumilus)
交叉反应多糖(a 型和 b 型流感嗜血杆菌,以及短小芽孢杆菌)
  • 批准号:
    8553872
  • 财政年份:
  • 资助金额:
    $ 0.7万
  • 项目类别:
Peptide-Protein Conjugate Vaccines
肽-蛋白结合疫苗
  • 批准号:
    8553920
  • 财政年份:
  • 资助金额:
    $ 0.7万
  • 项目类别:
Bordetellae, Brucellae and Haemophilus ducreyi
博氏菌、布鲁氏菌和杜克雷嗜血杆菌
  • 批准号:
    8351224
  • 财政年份:
  • 资助金额:
    $ 0.7万
  • 项目类别:
Cross Reacting Polysaccharides (H. influenzae types a and b, and B. pumilus)
交叉反应多糖(a 型和 b 型流感嗜血杆菌,以及短小芽孢杆菌)
  • 批准号:
    7734726
  • 财政年份:
  • 资助金额:
    $ 0.7万
  • 项目类别:
Shigellae
志贺氏菌属
  • 批准号:
    8149366
  • 财政年份:
  • 资助金额:
    $ 0.7万
  • 项目类别:
Bordetellae and Haemophilus ducreyi
博氏杆菌和杜克雷嗜血杆菌
  • 批准号:
    8149365
  • 财政年份:
  • 资助金额:
    $ 0.7万
  • 项目类别:
Vaccine development for Group B Neisseria meningitidis and Escherichia coli K1
B 组脑膜炎奈瑟菌和大肠杆菌 K1 的疫苗开发
  • 批准号:
    8553955
  • 财政年份:
  • 资助金额:
    $ 0.7万
  • 项目类别:
NMR Analysis of Synthetic Oligosaccharide Fragments of the OSP of E. coli O-148
大肠杆菌 O-148 OSP 合成寡糖片段的 NMR 分析
  • 批准号:
    7734847
  • 财政年份:
  • 资助金额:
    $ 0.7万
  • 项目类别:
Shigellae
志贺氏菌属
  • 批准号:
    7734840
  • 财政年份:
  • 资助金额:
    $ 0.7万
  • 项目类别:

相似海外基金

Structure based design of dengue subunit vaccines for inducing protective but not disease enhancing antibodies
基于结构的登革热亚单位疫苗设计,用于诱导保护性而非疾病增强性抗体
  • 批准号:
    10392040
  • 财政年份:
    2022
  • 资助金额:
    $ 0.7万
  • 项目类别:
Structure-based design of broadly protective coronavirus vaccines
基于结构的广泛保护性冠状病毒疫苗的设计
  • 批准号:
    10425024
  • 财政年份:
    2022
  • 资助金额:
    $ 0.7万
  • 项目类别:
Structure based design of dengue subunit vaccines for inducing protective but not disease enhancing antibodies
基于结构的登革热亚单位疫苗设计,用于诱导保护性而非疾病增强性抗体
  • 批准号:
    10612354
  • 财政年份:
    2022
  • 资助金额:
    $ 0.7万
  • 项目类别:
Structure and biophysical analysis aided design of novel toxoid vaccines for a major class of bacterial toxins.
结构和生物物理分析有助于针对主要一类细菌毒素设计新型类毒素疫苗。
  • 批准号:
    nhmrc : 2003435
  • 财政年份:
    2021
  • 资助金额:
    $ 0.7万
  • 项目类别:
    Ideas Grants
Structure-based design of coronavirus subunit vaccines
基于结构的冠状病毒亚单位疫苗设计
  • 批准号:
    10397563
  • 财政年份:
    2021
  • 资助金额:
    $ 0.7万
  • 项目类别:
Structure-based design of coronavirus subunit vaccines
基于结构的冠状病毒亚单位疫苗设计
  • 批准号:
    10415747
  • 财政年份:
    2021
  • 资助金额:
    $ 0.7万
  • 项目类别:
Structure based design of trimer interface epitope focused universal influenza vaccines
基于三聚体界面表位的通用流感疫苗的结构设计
  • 批准号:
    10361516
  • 财政年份:
    2020
  • 资助金额:
    $ 0.7万
  • 项目类别:
Structure based design of trimer interface epitope focused universal influenza vaccines
基于三聚体界面表位的通用流感疫苗的结构设计
  • 批准号:
    10576343
  • 财政年份:
    2020
  • 资助金额:
    $ 0.7万
  • 项目类别:
Structure-based design of coronavirus subunit vaccines
基于结构的冠状病毒亚单位疫苗设计
  • 批准号:
    9914088
  • 财政年份:
    2018
  • 资助金额:
    $ 0.7万
  • 项目类别:
Vaccines that Replicate the Neutralization-Competent Structure of the gp41 MPER
复制 gp41 MPER 中和能力结构的疫苗
  • 批准号:
    8263672
  • 财政年份:
    2012
  • 资助金额:
    $ 0.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了